CellSource Co

CellSource Co R&D per Employee

The R&D Spending per Employee of CellSource Co (4880.T) as of Oct 28, 2026 is 174,981.65 JPY. In the previous year, R&D Spending per Employee was 651,458.72 JPY — a change of -73.14% (lower).

R&D per Employee

174,981.65JPY

YoY

-73.14%

Last updated:

R&D Spending per Employee of CellSource Co is 2025 174,981.65 JPY. R&D Spending per Employee of CellSource Co was 2024 651,458.72 JPY. It decreases by -73.14% lower compared to the previous year.

The CellSource Co R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
63,119.27 JPY
Jan 1, 2019
73,385.32 JPY
Jan 1, 2020
99,238.53 JPY
Jan 1, 2021
652,853.21 JPY
Jan 1, 2022
803,321.10 JPY
Jan 1, 2023
664,706.42 JPY
Jan 1, 2024
651,458.72 JPY
Jan 1, 2025
174,981.65 JPY
The CellSource Co R&D per Employee history
YEARR&D per EmployeeYoY
174,981.65JPY-73.14%
651,458.72JPY-1.99%
664,706.42JPY-17.26%
803,321.10JPY+23.05%
652,853.21JPY+557.86%
99,238.53JPY+35.23%
73,385.32JPY+16.26%
63,119.27JPY+68.26%
37,513.76JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

R&D Spending per Employee of CellSource Co is 174,981.65 JPY in 2025.

R&D Spending per Employee of CellSource Co changed from 651,458.72 JPY to 174,981.65 JPY, representing a -73.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee CellSource Co since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's CellSource Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — CellSource Co

All Key Metrics — CellSource Co